Loading view.
This year CPhI & P-MEC China returns as a SMART event, combining 2 months of online event with a 3-day in-person event to help you connect for an extended period. “Virtual Expo Connect”, to be held from 21st April – 30th June 2022, is the digital extension of the physical CPhI & P-MEC China event that […]
Uncover the Robust Analytical Methods to Guarantee Safe, High Quality, Consistent & Efficacious Gene Therapy Products In the context of unprecedented gene therapy investment and clinical progress, with mounting regulatory scrutiny, Gene Therapy Analytical Development Europe will unite innovative biotech and pharma organisations to develop robust analytical tools to guarantee the consistency, quality, and safety […]
Integrate the Patient Voice to Develop Safer & More Effective Gene Therapies That Are Meaningful to Patients As investment in gene therapies continues to grow rapidly, more effectively engaging patients throughout development has become a priority for any company serious about building safer and more meaningful gene therapy programs. In this context, the 2nd Annual […]
SMi’s 6th Annual Conference Pre-Filled Syringes West Coast June 13 - 14, 2022 | San Diego, CA, USA SESSING DEVICE DEVELOPMENT AND REGULATION FOR ADVANCED INNOVATION SMi is delighted to announce the 6th annual Pre-Filled Syringes West Coast conference, to be held in San Diego. As part of SMi’s leading series of drug delivery device […]
Outcomes for HER2-expressing breast cancer are patients constantly improving; advancements in diagnostics, trial design and innovative drug design are at an all-time high; complementing the newly accessible HER2 ‘low' space and wider range of tumor indications; the last year has given us more progress in HER2-targeted therapies than ever before. As such, the HER2-Targeted Therapies Summit returns […]
Returning in 2022, the 2nd Tumor Myeloid-Directed Therapeutics Summit is the only industry-focused meeting dedicated to unlocking novel therapeutic potential through the myeloid compartment. This is your ultimate forum to identify, validate, and clinically progress myeloid targets to expand the oncologists toolkit and realize better responses by engaging myeloid anti-tumor function. Designed for experts working directly on myeloid-directed […]
Biotech companies are paving the way to displace the cochlear implant and cater for the huge unmet need in hearing and balance disorders. The field is booming with excitement, with pharma companies increasing investment into these pipelines in the race to successfully reverse hearing damage. Returning as an in-person event to Boston, the 2nd Inner Ear […]
CPhI & P-MEC China is Asia's leading pharmaceutical show for trading, knowledge sharing and networking. It spans all industry sectors along the pharmaceutical supply chain and is your one-stop platform to grow business in the 2nd largest pharma market in the world. CPhI & P-MEC China 2022, with the co-located shows FDF, bioLIVE, Pharma Excipients, […]
Built with biopharmaceutical industry insights, this in-person conference will delve into the latest advancements of non-viral RNA delivery systems such as LNPs, exosomes and polymers to set the scene for the translation of targeted, safe and durable delivery systems for RNA therapeutics and vaccines with improved formulation, distribution and tissue-specificity. Don't miss 20+ pioneering speakers from large […]
The 7th Microbiome Movement - Drug Development Summit returns to Boston at a pivotal time. As the microbiome therapeutic space matures, with more indications being pursued and more companies conducting trials, the focus of this event - now in its 7th year - is evolving to showcase these new studies. With this progress however comes new challenges, and we’re excited […]
Are you using TCRs to target solid tumors yet? With Immunocore having achieved commercialization for the first TCR therapy and Adaptimmune hot on their tail, 2022 is fast becoming the year for TCRs. Join the TCR-based Therapies for Solid Tumors Summit (June 27-29) to gain knowledge to accelerate the clinical development and improve the safety […]
Undoubtedly, the past two years have changed the pharma industry forever; new modalities are dominating pharma pipelines, drugs are increasing in potency, and the restrictions around product quality are tighter than ever before. It is integral that the HPAPI community comes together to apply expertise in ensuring operator safety, alongside product quality, to the future […]
Recover your password.
A password will be e-mailed to you.